World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
103
Citations
35498
World Ranking
648
National Ranking
378

Medicine

D-Index
103
Citations
35538
World Ranking
7417
National Ranking
3877

Research.com Recognitions

  • 1993 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Robert Yarchoan is affiliated with the National Institutes of Health in the United States. Their research primarily intersects the fields of medicine, with a significant focus on oncology, pathology and forensic medicine, infectious diseases, epidemiology, and physiology.

The scope of their work extensively covers viral-associated cancers and disorders, lymphoma diagnosis and treatment, histiocytic disorders and treatments, cytomegalovirus and herpesvirus research, CNS lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, and polyomavirus and related diseases.

Among the recent research papers associated with Robert Yarchoan are the following:

  • A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication, 2021, Nature Communications
  • Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy, 2022, Science Translational Medicine
  • GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection, 2020, mBio
  • Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma, 2022, Blood
  • Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes, 2020, Nature Genetics

Frequent coauthors collaborating with Robert Yarchoan include:

  • Ramya Ramaswami (47 joint publications)
  • Kathryn Lurain (45 joint publications)
  • Thomas S. Uldrick (30 joint publications)
  • David A. Davis (20 joint publications)
  • Denise Whitby (20 joint publications)

Robert Yarchoan has published frequently in the following venues:

  • Blood (8 publications)
  • Journal of Clinical Oncology (7 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (5 publications)
  • PLoS Pathogens (4 publications)
  • AIDS (4 publications)

In recognition of their contributions, Robert Yarchoan was named a Fellow of the American Association for the Advancement of Science (AAAS) in 1993.

Best Publications

  • Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

    L A Rubin;C C Kurman;M E Fritz;W E Biddison

  • Molecular targets for AIDS therapy

    Hiroaki Mitsuya;Robert Yarchoan;Samuel Broder

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Cancer Burden in the HIV-Infected Population in the United States

    Meredith S. Shiels;Ruth M. Pfeiffer;Mitchell H. Gail;H. Irene Hall

  • CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

    H Masur;F P Ognibene;R Yarchoan;J H Shelhamer

  • PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

    Robert Yarchoan;Rose V. Thomas;Jean Pierre Allain;Nanette Mcatee

  • In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

    Robert Yarchoan;Hiroaki Mitsuya;Rose V. Thomas;James M. Pluda

  • Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

    Hiroaki Mitsuya;Mikulas Popovic;Robert Yarchoan;Shuzo Matsushita

  • Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

    Raymond W Klecker;Jerry M Collins;Robert Yarchoan;Rose Thomas

  • A potential role for interleukin-7 in T-cell homeostasis

    Terry J. Fry;Elizabeth Connick;Judith Falloon;Michael Marcel Lederman

  • HIV-Associated Cancers and Related Diseases

    Robert Yarchoan;Thomas S. Uldrick

  • Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides.

    Robert Yarchoan;Hiroaki Mitsuya;Charles E. Myers;Samuel Broder

  • Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

    T Shirasaka;M F Kavlick;T Ueno;W Y Gao

  • Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.

    Robert Yarchoan;Robert Yarchoan;Pim Brouwers;Pim Brouwers;A. Robert Spitzer;A. Robert Spitzer;Jordan Grafman;Jordan Grafman;Jordan Grafman

  • Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1α and Hypoxia-Inducible Factor-2α in HEK293T Cells

    Victoria Wang;David A. Davis;Muzammel Haque;L. Eric Huang

  • Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

    Richard F. Little;Stefania Pittaluga;Nicole Grant;Seth M. Steinberg

  • Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.

    C.-F. Perno;R. Yarchoan;D. A. Cooney;N. R. Hartman

  • Development of Non-Hodgkin Lymphoma in a Cohort of Patients with Severe Human Immunodeficiency Virus (HIV) Infection on Long-Term Antiretroviral Therapy

    James M. Pluda;Robert Yarchoan;Elaine S. Jaffe;Irwin M. Feuerstein

  • Activity of Thalidomide in AIDS-Related Kaposi’s Sarcoma

    Richard F. Little;Kathleen M. Wyvill;James M. Pluda;Lauri Welles

  • Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells.

    Karen D. Jones;Yoshiyasu Aoki;Yoshiyasu Aoki;Yoshiyasu Aoki;Yuan Chang;Yuan Chang;Yuan Chang;Patrick S. Moore;Patrick S. Moore;Patrick S. Moore

  • Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

    PA Pizzo;J Eddy;J Falloon;FM Balis

Frequent Co-Authors

Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Samuel Broder
Samuel Broder Precision BioSciences
Giovanna Tosato
Giovanna Tosato National Institutes of Health
Stefania Pittaluga
Stefania Pittaluga National Institutes of Health
Denise Whitby
Denise Whitby Frederick National Laboratory for Cancer Research
Hiroaki Mitsuya
Hiroaki Mitsuya Kumamoto University
William D. Figg
William D. Figg National Institutes of Health
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Wyndham H. Wilson
Wyndham H. Wilson National Institutes of Health
David Venzon
David Venzon National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often requires strong foundational knowledge in healthcare and biology. For those interested in advancing their qualifications, there are various online programs tailored to meet different professional needs. For example, nurses looking to expand their scope can explore accelerated RN to NP programs that offer a faster route to becoming a nurse practitioner.

Additionally, registered nurses who began their careers without a traditional nursing degree might find online RN programs for non-nurses particularly beneficial. These programs bridge the gap by providing essential clinical and theoretical training remotely, which is ideal for working professionals.

For those aiming to specialize further, acute care certification for FNP is a valuable credential that enables Family Nurse Practitioners to handle complex patient cases in acute settings. This specialization complements immunology-focused careers well, given the critical role of immune responses in intensive care.

Finally, prospective students looking for more accessible entry points into nursing may consider ABSN programs with high acceptance rates. These accelerated bachelor’s programs cater to career changers and offer a streamlined path into the nursing field, laying a solid foundation for advanced studies in immunology and related healthcare disciplines.

Best Scientists Citing Robert Yarchoan

Trending Scientists